175 related articles for article (PubMed ID: 34210661)
1. Aspirin and gastrointestinal bleeding risk in older people.
Drug Ther Bull; 2021 Aug; 59(8):117. PubMed ID: 34210661
[No Abstract] [Full Text] [Related]
2. Daily aspirin for primary prevention increased risk for major GI bleeding in healthy older adults.
Hirsch C
Ann Intern Med; 2021 Jan; 174(1):JC4. PubMed ID: 33395330
[TBL] [Abstract][Full Text] [Related]
3. Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial.
Mahady SE; Margolis KL; Chan A; Polekhina G; Woods RL; Wolfe R; Nelson MR; Lockery JE; Wood EM; Reid C; Ernst ME; Murray A; Thao L; McNeil JJ
Gut; 2021 Apr; 70(4):717-724. PubMed ID: 32747412
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Benefits and risks of continuing aspirin in patients with peptic ulcer bleeding.
Ann Intern Med; 2010 Jan; 152(1):I-20. PubMed ID: 19949137
[No Abstract] [Full Text] [Related]
5. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
Lanas A
Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.
Chan FKL; Ching JYL; Tse YK; Lam K; Wong GLH; Ng SC; Lee V; Au KWL; Cheong PK; Suen BY; Chan H; Kee KM; Lo A; Wong VWS; Wu JCY; Kyaw MH
Lancet; 2017 Jun; 389(10087):2375-2382. PubMed ID: 28410791
[TBL] [Abstract][Full Text] [Related]
7. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
[TBL] [Abstract][Full Text] [Related]
8. Daily low-dose aspirin: beware of GI bleeding.
Johns Hopkins Med Lett Health After 50; 2012 Mar; 24(1):6. PubMed ID: 22493823
[No Abstract] [Full Text] [Related]
9. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
11. Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: a post-hoc analysis of the OBERON trial.
Scheiman JM; Lanas A; Veldhuyzen van Zanten S; Baldycheva I; Svedberg LE; Nagy P
Int J Cardiol; 2015 Mar; 182():500-2. PubMed ID: 25618787
[No Abstract] [Full Text] [Related]
12. Prior oral proton-pump inhibitor use is associated with reduced severity of aspirin-related upper gastrointestinal bleeding in older people.
Ayonrinde OT; Walldorf N; Chan N; Foo NY; Kulkarni T; Olynyk JK; Sanfilippo FM
Intern Med J; 2022 Apr; 52(4):663-666. PubMed ID: 35419961
[TBL] [Abstract][Full Text] [Related]
13. Reinitiating aspirin therapy for primary prevention of cardiovascular events in a patient post-aspirin-induced upper gastrointestinal bleed: a case report and review of literature.
Adly G; Plakogiannis R
Ann Pharmacother; 2013 Feb; 47(2):e8. PubMed ID: 23386069
[TBL] [Abstract][Full Text] [Related]
14. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Moayyedi P; Eikelboom JW; Bosch J; Connolly SJ; Dyal L; Shestakovska O; Leong D; Anand SS; Störk S; Branch KRH; Bhatt DL; Verhamme PB; O'Donnell M; Maggioni AP; Lonn EM; Piegas LS; Ertl G; Keltai M; Cook Bruns N; Muehlhofer E; Dagenais GR; Kim JH; Hori M; Steg PG; Hart RG; Diaz R; Alings M; Widimsky P; Avezum A; Probstfield J; Zhu J; Liang Y; Lopez-Jaramillo P; Kakkar A; Parkhomenko AN; Ryden L; Pogosova N; Dans A; Lanas F; Commerford PJ; Torp-Pedersen C; Guzik T; Vinereanu D; Tonkin AM; Lewis BS; Felix C; Yusoff K; Metsarinne K; Fox KAA; Yusuf S;
Gastroenterology; 2019 Aug; 157(2):403-412.e5. PubMed ID: 31054846
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
Valkhoff VE; Sturkenboom MC; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
[TBL] [Abstract][Full Text] [Related]
16. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
Brusselaers N; Lagergren J
BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
[TBL] [Abstract][Full Text] [Related]
17. Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis.
Tran-Duy A; Vanmolkot FH; Joore MA; Hoes AW; Stehouwer CD
Int J Clin Pract; 2015 Oct; 69(10):1088-111. PubMed ID: 25846476
[TBL] [Abstract][Full Text] [Related]
18. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
ASPREE Investigator Group
Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced gastrointestinal bleeding].
Fischbach W
Internist (Berl); 2019 Jun; 60(6):597-607. PubMed ID: 31076795
[TBL] [Abstract][Full Text] [Related]
20. Prevention of damage induced by aspirin in the GI tract.
Scheiman JM
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):153-62. PubMed ID: 22542153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
